A thread for ME/CFS-related news from Estonia, Latvia and Lithuania
*************************************************
Coaching to Strengthen Critical Success Factors in Integrative Care for Chronic Fatigue Patients: The Patient Needs-Resources Model 2023,Araja et al
Diana Araja 1*, Angelika Krumina 2, Zaiga Nora-Krukle 1, Marion E. Schneider 3, Uldis Berkis 4 and Modra Murovska 1
Rīga Stradiņš University
A paper funded by the Latvian Council of Science does not seem to have much to do with what it was funded for (ME/CFS biomarkers). That's a great shame given someone probably worked very hard to get that funding arranged.
*************************************************
Coaching to Strengthen Critical Success Factors in Integrative Care for Chronic Fatigue Patients: The Patient Needs-Resources Model 2023,Araja et al
Diana Araja 1*, Angelika Krumina 2, Zaiga Nora-Krukle 1, Marion E. Schneider 3, Uldis Berkis 4 and Modra Murovska 1
Rīga Stradiņš University
A paper funded by the Latvian Council of Science does not seem to have much to do with what it was funded for (ME/CFS biomarkers). That's a great shame given someone probably worked very hard to get that funding arranged.
Funding for this is listed as
"The research was supported by the Horizon 2020 Project/Agreement No. 952376 “Reducing networking gaps between Riga Stradins University (RSU) and internationally leading counterparts in viral infection-induced autoimmunity research (VirA)” and Latvian Council of Science FARP Grant Number: LZP-2019/1-0380, “Selection of biomarkers in ME/CFS for patient stratification and treatment surveillance/optimization.”"
I fail to see how this paper could be even remotely considered to be relevant to "Selection of biomarkers in ME/CFS for patient stratification and treatment surveillance/optimization.".
Last edited: